CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†Maria A. González-Carmona, Volker Schmitz, Tilman Sauerbruch et al.|Hepatology|2008Cited by 67
Increase of In Vivo Antitumoral Activity by CD40L (CD154) Gene Transfer Into Pancreatic Tumor Cell-Dendritic Cell HybridsCarsten Ziske, Ingo G.H. Schmidt‐Wolf, Patricia E. Etzrodt et al.|Pancreas|2009Cited by 13
309 CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS INDUCED AGAINST HCC BY AFP- OR TUMOR LYSATE-PULSED DENDRITIC CELLS CAN BE SIGNIFICANTLY ENHANCED BY ADENOVIRAL TRANSDUCTION WITH IL-12Maria A. González-Carmona, Wolfgang H. Caselmann, Anne B. Vogt et al.|Journal of Hepatology|2009Cited by 0
Inhibition des Tumorwachstums von etablierten, subkutanen AFP-exprimierenden HCC durch die Kombination von AFP- und IL-12-exprimierenden dendritischen Zellen (DC) in vivoMA González-Carmona, WH Caselmann, Christophe Schneider et al.|Zeitschrift für Gastroenterologie|2009Cited by 0
Inhibition des Tumorwachstums durch Vakzinierung mit IL–12/AFP-exprimierenden dendritischen Zellen in einem murinen HCC-ModellM Gonzales-Carmona, WH Caselmann, Christophe Schneider et al.|Zeitschrift für Gastroenterologie|2008Cited by 0